Allurion Technologies Inc. (ALUR)
OQB · Healthcare · Medical Devices
$0.66
-7.17%
Closing price as of 2026-06-12 · Source: TEK2day Finance
Key Metrics
Market Cap
$9.9M
Shares Outstanding
15.0M
P/S (TTM)
0.8x
Exchange
OQB
Currency
USD
About Allurion Technologies Inc.
Allurion Technologies Inc. focuses on developing a weight loss platform for overweight people in Spain, France, Turkey, and internationally. Its Allurion Program platform offers the Allurion Smart Capsule, a swallowable and procedure-less intragastric balloon for weight loss, and access to the Allurion Virtual Care Suite, a digital therapeutic that combines AI-powered remote patient monitoring tools with a behavior change program. The company is headquartered in Natick, Massachusetts.
Quarterly Financials
| Metric | 2025-06-30 | 2025-09-30 | 2025-12-31 | 2026-03-31 |
|---|---|---|---|---|
| Revenue | 3.4M | 2.7M | 3.6M | 2.9M |
| Gross Profit | 2.5M | 1.3M | 1.6M | 1.2M |
| Operating Income | -7.0M | -9.6M | -6.3M | -3.7M |
| Net Income | -9.3M | -11.9M | -6.0M | -6.1M |
| Diluted EPS | $-1.28 | $-1.53 | $nan | $-0.46 |
Annual Financials
| Metric | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|---|
| Revenue | 64.2M | 53.5M | 32.1M | 15.2M |
| Gross Profit | 50.7M | 41.5M | 21.5M | 9.6M |
| Operating Income | -32.0M | -79.1M | -50.2M | -30.2M |
| Net Income | -37.7M | -82.8M | -7.2M | -28.8M |
| Diluted EPS | $-21.85 | $-57.75 | $-11.64 | $-3.81 |